
This fund is designed to deliver investment returns that closely reflect the performance of the Nifty 500 Index. Its primary objective is to track the movements of this benchmark, measured before any of the fund's own management fees or operational expenses are subtracted.
Is IND's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

HONG KONG, Oct 9, 2026 - (ACN Newswire) - Everest Medicines (1952.HK) announced the appointments of Lakshmi Srinivasan, PhD, as Senior Vice President, Head of T

AARD DEADLINE NOTICE: Faruqi and Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026PR NewswireNEW YORK,

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class ActionPR NewswireSAN FRANCISCO,

Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli

Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 De